Lorcan McGarvey
Effect of aclidinium bromide on cough and sputum symptoms in moderate-to-severe COPD in three phase III trials
McGarvey, Lorcan; Morice, Alyn H.; Smith, Jaclyn A.; Birring, Surinder S.; Chuecos, Ferran; Seoane, Beatriz; Jarreta, Diana
Authors
Professor Alyn Morice A.H.Morice@hull.ac.uk
Foundation Chair and Professor of Respiratory Medicine
Jaclyn A. Smith
Surinder S. Birring
Ferran Chuecos
Beatriz Seoane
Diana Jarreta
Abstract
© 2016, BMJ Publishing Group. All rights reserved. Background: Cough and sputum are troublesome symptoms in chronic obstructive pulmonary disease (COPD) and are associated with adverse outcomes. The efficacy of aclidinium bromide 400 μg twice daily in patients with stable COPD has been established in two phase III studies (ACCORD COPD I and ATTAIN) and a phase IIIb active-comparator study. This analysis evaluated cough-related symptoms across these studies. Method: Patients were randomised to placebo, aclidinium 200 μg or 400 μg twice daily in ACCORD (12 weeks) and ATTAIN (24 weeks), or to placebo, aclidinium 400 μg twice daily or tiotropium 18 μg once daily (6-week active-comparator study). Analysed end points included changes from baseline in Evaluating Respiratory Symptoms (E-RS; formerly known as EXAcerbations of Chronic pulmonary disease Tool), total and cough/sputum scores and frequency/severity of morning and night-time cough and sputum symptoms. Results: Data for 1792 patients were evaluated. E-RS cough/sputum domain scores were significantly reduced with aclidinium 400 μg versus placebo in ATTAIN (−0.7 vs −0.3, respectively; p
Citation
McGarvey, L., Morice, A. H., Smith, J. A., Birring, S. S., Chuecos, F., Seoane, B., & Jarreta, D. (2016). Effect of aclidinium bromide on cough and sputum symptoms in moderate-to-severe COPD in three phase III trials. BMJ Open Respiratory Research, 3(1), Article e000148. https://doi.org/10.1136/bmjresp-2016-000148
Journal Article Type | Article |
---|---|
Acceptance Date | Oct 24, 2016 |
Online Publication Date | Dec 8, 2016 |
Publication Date | 2016 |
Deposit Date | May 12, 2022 |
Publicly Available Date | May 16, 2022 |
Journal | BMJ Open Respiratory Research |
Electronic ISSN | 2052-4439 |
Publisher | BMJ Publishing Group |
Peer Reviewed | Peer Reviewed |
Volume | 3 |
Issue | 1 |
Article Number | e000148 |
DOI | https://doi.org/10.1136/bmjresp-2016-000148 |
Public URL | https://hull-repository.worktribe.com/output/3609892 |
Files
Published article
(1.3 Mb)
PDF
Publisher Licence URL
http://creativecommons.org/licenses/by/4.0
Copyright Statement
This is an Open Access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 4.0) license, which permits others to distribute, remix, adapt and build upon this work, for commercial use, provided the original work is properly cited. See: http://creativecommons.org/licenses/by/4.0/
You might also like
A survey of UK respiratory specialists’ opinion on the management of chronic cough
(2024)
Journal Article
Chronic cough: symptom, sign or disease?
(2024)
Journal Article
Downloadable Citations
About Repository@Hull
Administrator e-mail: repository@hull.ac.uk
This application uses the following open-source libraries:
SheetJS Community Edition
Apache License Version 2.0 (http://www.apache.org/licenses/)
PDF.js
Apache License Version 2.0 (http://www.apache.org/licenses/)
Font Awesome
SIL OFL 1.1 (http://scripts.sil.org/OFL)
MIT License (http://opensource.org/licenses/mit-license.html)
CC BY 3.0 ( http://creativecommons.org/licenses/by/3.0/)
Powered by Worktribe © 2025
Advanced Search